NCT06320613

Brief Summary

The aim of this study was to investigate the effect of implementing snap-needle therapy combined with ginger paste during anesthesia recovery on the recovery of gastrointestinal function after gynecological laparoscopy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 20, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

March 20, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

March 1, 2024

Last Update Submit

March 12, 2024

Conditions

Keywords

Gastrointestinal MotilityRecovery of FunctionPONV

Outcome Measures

Primary Outcomes (13)

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 0.5 hours postoperatively.

    Measured at 0.5 hours postoperatively.

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 1 hours postoperatively.

    Measured at 1 hours postoperatively.

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 3 hours postoperatively.

    Measured at 3 hours postoperatively.

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 6 hours postoperatively.

    Measured at 6 hours postoperatively.

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 12 hours postoperatively.

    Measured at 12 hours postoperatively.

  • Postoperative nausea and vomiting

    The Index of Nausea and Vomiting and Retching (INVR) was used in this study. The scale consists of 8 items with 3 dimensions, which can quantify the number of occurrences, duration and severity of symptoms. The scale is scored using the Likert method, with a total of 32 points on a 5-point scale ranging from 0 to 4. The higher the score, the more severe the symptoms of nausea, vomiting, and dry heaving (entries 1, 6, and 7 are reverse scored). According to the score, nausea, vomiting and dry heaving symptoms can be categorized into five grades: 0, I, II, III and IV, and grade ≥I means that the symptom occurs. The severity and incidence of PONV at 24 hours postoperatively.

    Measured at 24 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 0.5 hours postoperatively.

    Measured at 0.5 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 1 hours postoperatively.

    Measured at 1 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 3 hours postoperatively.

    Measured at 3 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 6 hours postoperatively.

    Measured at 6 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 12 hours postoperatively.

    Measured at 12 hours postoperatively.

  • Abdominal distention

    The severity and incidence of Abdominal distention at 24 hours postoperatively.

    Measured at 24 hours postoperatively.

  • Time to first flatus

    Record the time of the first flatus. The earlier the time of first flatus, the earlier the time of recovery of gastrointestinal function.

    Approximately 24 hours after surgery.

Secondary Outcomes (9)

  • Postoperative pain response

    Measured at 0.5 hours postoperatively.

  • Postoperative pain response

    Measured at 1 hours postoperatively.

  • Postoperative pain response

    Measured at 3 hours postoperatively.

  • Postoperative pain response

    Measured at 6 hours postoperatively.

  • Postoperative pain response

    Measured at 12 hours postoperatively.

  • +4 more secondary outcomes

Study Arms (3)

Experimental group acupuncture(snap-needle)

ACTIVE COMPARATOR

Patients in the acupuncture group received acupuncture therapy (snap-needle therapy) for 24 hours. Results of the study were collected at six assessment periods of 0-0.5 h, 0-1 h, 1-3 h, 4-6h, 6-12 h, and 12-24 h after anesthesia. Conducted by an independent researcher.

Other: Acupuncture therapy

Experimental Ginger

ACTIVE COMPARATOR

Patients in the Ginger Acupuncture Point Patch group received ginger patch therapy and the ginger patch was removed within 6h. Study results were collected at six assessment periods of 0-0.5h, 0-1h, 1-3h, 4-6h, 6-12h, and 12-24h after anesthesia. Conducted by an independent researcher.

Other: Ginger Acupuncture Point Patch

Experimental group Acupuncture combined with ginger

ACTIVE COMPARATOR

Patients in the Acupuncture combined with ginger group received acupuncture treatment (snap-needle therapy) combined with ginger compresses, which were removed within 6h and snap-needles were removed after 24 hours. Study results were collected at six assessment periods of 0-0.5h, 0-1h, 1-3h, 4-6h, 6-12h, and 12-24h after anesthesia. Conducted by an independent researcher.

Other: Acupuncture therapyOther: Ginger Acupuncture Point Patch

Interventions

After disinfecting (alcohol or 0.9% Normal saline) the skin at the acupuncture point, use small tweezers to clip the handle of the needle, remove the adhesive tape and stab the acupuncture point at a perpendicular angle, and then press the thumb with moderate pressure on the snap-needle embedded needle site in order for the patient to feel localized soreness and distension as appropriate. The snap-needle was removed after 24 hours, and the pressing time point remained unchanged.

Also known as: Qin acupuncture therapy, snap-needle therapy
Experimental group Acupuncture combined with gingerExperimental group acupuncture(snap-needle)

Ginger was thinly sliced and then cut into 2-3cm diameter ginger discs according to a circular mold and covered with a sterile circular dressing. The ginger compress was removed within 6 hours.

Experimental GingerExperimental group Acupuncture combined with ginger

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I or II;
  • Performing gynecologic laparoscopic procedures under general anesthesia;

You may not qualify if:

  • Age ≤ 18 or ≥65;
  • The patient has a previous history of PONV, digestive disorders, etc;
  • Ulcers, infections, and skin tears at acupressure and acupuncture (snap-needle) treatment sites;
  • Patients allergic to ginger;
  • Inability to follow protocol or refusal to participant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lin Cheng

Weifang, Shandong, 261000, China

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Lin Cheng, B.S

    Weifang People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lin Cheng, B.S

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pricipal Investigator

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 20, 2024

Study Start

March 20, 2024

Primary Completion

September 20, 2024

Study Completion

September 20, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations